CLINICAL_TRIALS
trial_result
· 2013-06-26
Clinical Trial Update: A Study to Assess AFM13 in Patients With Hodgkin Lymphoma [Phase 1]
Summary
This update reports the completion of a Phase 1 clinical trial evaluating AFM13 in patients with Hodgkin lymphoma, sponsored by Affimed GmbH.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Affimed GmbH | Conditions: Hodgkin Lymphoma | Phase 1 | Status: COMPLETED